This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More
Exelixis Inc
EXEL : NASDAQ : Health Care
$1.76 0.04 | 2.33%
Today's Range: 1.68 - 1.76
Avg. Daily Volume: 4,033,500
11/26/14 - 4:00 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
EXEL EXELIXIS INC 1.74 339.68 n/m 22.11 -36.49
RNA PROSENSA HOLDING NV 11.51 415.47 n/m 28.16 954.21
DVAX DYNAVAX TECHNOLOGIES CORP 14.51 381.51 n/m 11.60 13.63
ZIOP ZIOPHARM ONCOLOGY INC 3.71 381.06 n/m 1.23 54.12
TKMR TEKMIRA PHARMACEUTICALS CORP 16.11 359.48 n/m 16.81 39.51
IMMU IMMUNOMEDICS INC 3.75 349.25 n/m 4.62 -50.95
FPRX FIVE PRIME THERAPEUTICS INC 15.74 339.21 n/m 18.37 161.28
CTIC CTI BIOPHARMA CORP 2.17 325.70 n/m 75.17 4090.18
ARWR ARROWHEAD RESEARCH CORP 5.74 303.70 n/m 0.17 -40.21
SVA SINOVAC BIOTECH LTD 5.01 279.04 83.50 65.73 -4.98
BTX BIOTIME INC 3.30 274.30 n/m 5.26 39.69
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

EXEL Ind Avg S&P 500
n/m 64.35 19.91
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs